谷歌浏览器插件
订阅小程序
在清言上使用

Evaluating the Place of Low-Molecular-Weight Heparin in the Acute Coronary Syndromes

CLINICAL CARDIOLOGY(2001)

引用 23|浏览11
暂无评分
摘要
Clinical CardiologyVolume 24, Issue S1 p. 20-22 Original ArticleFree Access Evaluating the place of low-molecular-weight heparin in the management of acute coronary syndromes James H. Chesebro M.D., James H. Chesebro M.D. The Cardiovascular Institute, Mount Sinai Hospital, New York, New York, USASearch for more papers by this authorFREEK W. A. Verheugt M.D., F.A.C.C., F.E.S.C., FREEK W. A. Verheugt M.D., F.A.C.C., F.E.S.C. Heartcenter, University Medical Center, University of Nijmegen, Nijmegen, The NetherlandsSearch for more papers by this authorFrederic Kontny M.D., PH.D., Frederic Kontny M.D., PH.D. Department of Cardiology, The Heart and Lung Centre, Ullevǎl University, Oslo, NorwaySearch for more papers by this authorEDWARD T. A. Fry M.D., EDWARD T. A. Fry M.D. St. Vincent Hosptial, The Care Group, LLC, Indiana Heart Institute, Indianapolis, Indiana, USASearch for more papers by this authorLars Wallentin M.D., PH.D., Lars Wallentin M.D., PH.D. Department of Cardiology, University Hospital, Uppsala, SwedenSearch for more papers by this authorA. John CAMM M.D., F.A.C.C, F.E.S.C., A. John CAMM M.D., F.A.C.C, F.E.S.C. St. George's Hospital Medical School, London, U.K.Search for more papers by this authorHeinrich Bechtold M.D., Heinrich Bechtold M.D. Department of Internal Medicine, Crailsheim Hospital, Crailsheim, GermanySearch for more papers by this author James H. Chesebro M.D., James H. Chesebro M.D. The Cardiovascular Institute, Mount Sinai Hospital, New York, New York, USASearch for more papers by this authorFREEK W. A. Verheugt M.D., F.A.C.C., F.E.S.C., FREEK W. A. Verheugt M.D., F.A.C.C., F.E.S.C. Heartcenter, University Medical Center, University of Nijmegen, Nijmegen, The NetherlandsSearch for more papers by this authorFrederic Kontny M.D., PH.D., Frederic Kontny M.D., PH.D. Department of Cardiology, The Heart and Lung Centre, Ullevǎl University, Oslo, NorwaySearch for more papers by this authorEDWARD T. A. Fry M.D., EDWARD T. A. Fry M.D. St. Vincent Hosptial, The Care Group, LLC, Indiana Heart Institute, Indianapolis, Indiana, USASearch for more papers by this authorLars Wallentin M.D., PH.D., Lars Wallentin M.D., PH.D. Department of Cardiology, University Hospital, Uppsala, SwedenSearch for more papers by this authorA. John CAMM M.D., F.A.C.C, F.E.S.C., A. John CAMM M.D., F.A.C.C, F.E.S.C. St. George's Hospital Medical School, London, U.K.Search for more papers by this authorHeinrich Bechtold M.D., Heinrich Bechtold M.D. Department of Internal Medicine, Crailsheim Hospital, Crailsheim, GermanySearch for more papers by this author First published: 03 February 2009 https://doi.org/10.1002/clc.4960241307Citations: 1AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat No abstract is available for this article.Citing Literature Volume24, IssueS1Supplement: Acute Coronary Care and Beyond: The Expanding Role of Low‐Molecular‐Weight HeparinMarch 2001Pages 20-22 RelatedInformation
更多
查看译文
关键词
Heparin-Induced Thrombocytopenia,Clinical Features
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要